Content

1. The evolving diagnostic landscape for tuberculosis
2. A decade of building India’s TB Champion movement

The evolving diagnostic landscape for tuberculosis

Why in News ?

• WHO recommended near point-of-care molecular tests (NPOC-NAAT), tongue swab sampling, and sputum pooling strategies, marking a major shift toward rapid, decentralised and scalable TB diagnosis globally.
• The developments coincide with World TB Day (24 March) and India’s push under National Tuberculosis Elimination Programme (NTEP) and TB Mukt Bharat Abhiyaan, highlighting diagnostics as the key bottleneck in TB elimination.

Relevance

• GS II (Health Governance): Public health systems, NTEP implementation
• GS III (Science & Tech): Molecular diagnostics, AI in healthcare
• GS III (Economy): Health expenditure, productivity loss

Practice Question

Q. “Diagnostics remain the weakest link in India’s tuberculosis elimination strategy.” Examine in the context of emerging technologies and systemic challenges.(250 Words)

Basics 

Tuberculosis (TB)

• TB is a bacterial infectious disease caused by Mycobacterium tuberculosis, primarily affecting lungs (pulmonary TB) but also other organs (extra-pulmonary TB ~25% cases in India).
• India accounts for ~27% of global TB burden (WHO Global TB Report), making it the highest TB burden country globally.

NTEP (National Tuberculosis Elimination Programme)

• Flagship programme under Ministry of Health & Family Welfare, earlier known as RNTCP, focusing on universal access to TB diagnosis, free treatment, and prevention strategies.
• Implements tools like:
  • CBNAAT (GeneXpert)
  • Truenat (indigenous molecular test)
  • Active Case Finding (ACF)
• Integrated with Nikshay portal for digital tracking of TB patients and treatment adherence.

Recent WHO-Recommended Innovations 

• NPOC Molecular Tests (Near Point-of-Care NAAT):
  • Allow rapid TB diagnosis at primary healthcare level, reducing dependence on centralised labs and sophisticated infrastructure.
• Tongue Swab Testing:
  • Uses non-sputum samples, beneficial for children, elderly, and patients unable to produce sputum, improving inclusivity of diagnostics.
• Sputum Pooling Strategy:
  • Combines samples for testing to increase efficiency and reduce costs in high-burden settings, especially useful for mass screening programmes.

Shift in India’s Diagnostic Strategy

• India historically relied on Sputum Smear Microscopy, which has low sensitivity and cannot detect drug resistance, leading to missed or delayed diagnosis.
• Since 2016, India scaled up molecular diagnostics (CBNAAT, Truenat), enabling:
  • Rapid detection of TB and Rifampicin resistance
• Current focus is on:
  • Universal upfront NAAT testing before treatment initiation
  • Decentralised testing at primary healthcare level

Technology Integration in TB Diagnosis

AI-enabled Chest X-Ray (CXR)

• India is deploying portable CXR machines with AI under TB Mukt Bharat Abhiyaan, enabling active case finding in communities via mobile vans.
• AI helps in:
  • Rapid detection of lung abnormalities
  • Reducing dependence on radiologists
  • Opportunistic screening from routine X-rays in hospitals

Field-Level Impact

• Transition from hospital-based diagnosis → community-based screening, improving early detection and reducing transmission.
• However, requires on-the-spot sputum collection and referral systems to avoid diagnostic dropouts (attrition).

Key Data & Evidence

• India contributes ~27% of global TB cases, with significant burden of drug-resistant TB (DR-TB).
• Extra-pulmonary TB accounts for ~25% cases, often underdiagnosed due to complex testing requirements.
• Asymptomatic TB prevalence is high (National TB Survey), making symptom-based screening inadequate.

Critical Challenges

• Uneven access to molecular testing, particularly in rural, tribal, and hard-to-reach areas, due to weak sample collection and transport systems.
• Diagnostic delays in drug-resistance testing, leading to inappropriate treatment and continued transmission.
• High burden of asymptomatic TB, where symptom-based screening fails, necessitating radiological and AI-based screening expansion.
• Difficulty in diagnosing children and EP-TB, due to:
  • Low bacterial load
  • Inability to produce sputum
• High out-of-pocket expenditure, especially when diagnosis occurs in private sector without regulation or standardisation.

Emerging Research & Innovation Needs

• Need for biomarkers to predict progression from TB infection → active disease, enabling targeted preventive therapy (TPT).
• Development of non-sputum diagnostics (saliva, stool tests) for children and vulnerable populations.
• Improved tools for extra-pulmonary TB diagnosis, including AI-enabled ultrasound + molecular testing combinations.
• Strengthening implementation research in India-specific contexts, ensuring tools are cost-effective and scalable.

System-Level Gaps

• Lack of diagnostic network optimisation, leading to inefficient placement and utilisation of tools across regions.
• Weak integration between public and private healthcare systems, affecting standardisation of diagnosis and reporting.
• Limited health system capacity (human resources, training) to effectively deploy AI and advanced diagnostics at scale.

Way Forward

• Achieve 100% upfront molecular testing (NAAT) before treatment initiation through strengthened sample transport and decentralised labs.
• Expand AI-enabled CXR screening with integrated referral and sputum collection systems, reducing diagnostic delays.
• Develop clear national diagnostic algorithms combining AI + molecular tests, ensuring operational feasibility and standardisation.
• Strengthen ICMR-led evaluation and Health Technology Assessment (HTA) for evidence-based adoption of new diagnostic tools.
• Promote public-private integration, ensuring universal access, affordability, and reduced out-of-pocket expenditure.

Prelims Pointers

• CBNAAT (GeneXpert): Molecular test detecting TB + Rifampicin resistance
• Truenat: Indigenous portable molecular diagnostic tool
• NPOC-NAAT: Near point-of-care molecular test
• EP-TB: Extra-pulmonary TB (~25% cases in India)
• Nikshay Portal: Digital TB patient tracking system

A decade of building India’s TB Champion movement

Why in News ?

• World TB Day (24 March 2026): Editorial focus highlights role of TB survivors (“TB Champions”) in addressing stigma, improving treatment adherence, and strengthening community participation in India’s TB elimination efforts.
• Comes amid India’s push under National Tuberculosis Elimination Programme (NTEP), where despite 25 lakh+ annual cases, social stigma and treatment dropouts remain major barriers to elimination.

Relevance

• GS II (Governance): Community participation, public health delivery
• GS I (Society): Stigma, social exclusion, vulnerable groups

Practice Question

Q. “Tuberculosis is as much a social disease as a medical condition.” Discuss the role of community-led initiatives like the TB Champion movement in achieving TB elimination in India.(250 Words)

Basics 

TB Burden & Nature of Challenge

• India diagnoses and treats over 25 lakh TB patients annually, making it the highest TB burden country globally (~27% of global cases as per WHO).
• TB is not just a medical condition but a socio-economic disease, deeply linked with poverty, malnutrition, overcrowding, and social exclusion.
• Despite free diagnosis and treatment under NTEP, stigma, fear, and misinformation delay care-seeking and reduce treatment adherence.

What are TB Champions?

• TB Champions are TB survivors trained as peer supporters, counsellors, and community advocates, institutionalised under NTEP through “Survivor to Champion” model.
• They use lived experience of illness and recovery to provide:
  • Emotional support and counselling
  • Treatment literacy and motivation
  • Community awareness and stigma reduction
• Developed initially by organisations like REACH, now formally integrated into government TB strategy.

Core Problem Highlighted

• TB response has historically been “biomedical-centric”, focusing on diagnostics and drugs, while neglecting psychosocial dimensions such as stigma, loneliness, and discrimination.
• TB remains one of the most stigmatised diseases in India, disproportionately affecting:
  • Women (marriage, social exclusion)
  • Transgender communities
  • Children and elderly
• This leads to:
  • Delayed diagnosis
  • Treatment discontinuation
  • Hidden cases and continued transmission

Shift Toward Community-Centric Model

• Emergence of TB Champion movement (since ~2016) has challenged assumption that survivors do not engage post-treatment, proving that community-led models are viable and effective.
• TB Champions act as:
  • Bridges between health system and communities
  • First-level counsellors improving trust in public health services
• Reinforces principle that disease elimination requires social mobilisation, not just medical intervention.

Impact of TB Champions

• Improved treatment adherence and completion rates, due to peer counselling and emotional support during long treatment cycles (6–24 months).
• Reduction in self-stigma and discrimination, as survivors publicly share their journeys and normalise TB as curable disease.
• Enhanced awareness at grassroots level, through community meetings, panchayat engagement, and last-mile outreach.
• Creation of survivor-led networks across states, acting as support systems and advocacy platforms for TB-affected individuals.

Persistent Challenges

• Stigma and social exclusion remain deeply entrenched, especially in rural and conservative communities, limiting effectiveness of purely clinical interventions.
• Sustainability concerns, as TB Champion networks often depend on external funding and NGO support, lacking long-term institutional backing.
• Limited integration of psychosocial care within formal health system, with continued focus on diagnostics and treatment targets.
• Economic burden persists even after cure, including loss of livelihood, long-term health impacts, and social marginalisation.

Structural Gaps in TB Response

• Weak emphasis on community engagement strategies within health policy frameworks, despite evidence of their effectiveness.
• Inadequate multi-sectoral convergence (health, nutrition, social welfare, livelihood support) needed to address TB’s social determinants.
• Lack of formal recognition, incentives, and career pathways for TB Champions, limiting scalability of the model.

Way Forward

• Institutionalise TB Champion model within NTEP with formal funding, incentives, and training frameworks, ensuring long-term sustainability.
• Integrate psychosocial support and counselling services into TB care protocols, making treatment patient-centric rather than disease-centric.
• Strengthen community engagement through Panchayats, SHGs, and local governance institutions, enhancing last-mile awareness and trust-building.
• Promote multi-sectoral approach (nutrition support, social protection, livelihood schemes) to address root causes of TB vulnerability.
• Develop self-sustaining socio-economic models for survivor networks, reducing dependence on external funding.

Prelims Pointers

• NTEP: India’s flagship TB programme (earlier RNTCP)
• Nikshay Portal: Digital tracking of TB patients
• TB Champions: Survivor-led peer support model under NTEP
• India’s TB elimination target: 2025 (ahead of SDG 2030)